This is a news story, published by Yahoo Finance, that relates primarily to CVS news.
For more health policy news, you can click here:
more health policy newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about health policy, you might also like this article about
drug infusion services provider. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest core infusion services business news, CVS Health news, news about health policy, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
other infusion providersReuters
•81% Informative
CVS Health is exiting its core infusion services business and plans to either close or sell 29 related regional pharmacies.
Details of the strategic shift were announced in a CVS corporate memo dated Oct. 8 and seen by Reuters .
CVS bought Coram LLC , a drug infusion services provider, for $2.1 billion in 2013 .
VR Score
90
Informative language
94
Neutral language
83
Article tone
formal
Language
English
Language complexity
64
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links